Director at Lundbeck: "Some whistleblowers write in a way that makes it completely impossible to investigate anything at all"
![Photo: Jens Dresling](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13598303.ece/ALTERNATES/schema-16_9/doc7j1pz3uhs84gidh43nz.jpg)
Pharmaceutical firm Lundbeck sometimes has to throw in the towel when it comes to following up on whistleblower leads.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Lundbeck finds new head of clinical development
For subscribers